U.S. moves to curb influence of WHO cancer agency
The Trump administration is targeting the International Agency for Research on Cancer, a WHO body whose findings are often cited in U.S. litigation over common products.
The Trump administration has moved to cut the influence of the International Agency for Research on Cancer (IARC), a World Health Organization agency. The IARC’s classifications and research are frequently used by trial lawyers to launch high‑stakes lawsuits in U.S. courts over everyday products.